Canakinumab for Treatment of Adult Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): A Phase 2, Multi-Centre, Placebo-Controlled Study
Keyword(s):
Phase 2
◽
2014 ◽
Vol 73
(Suppl 2)
◽
pp. 322.1-322
2019 ◽
Vol 19
(6)
◽
pp. 459-468
◽
Keyword(s):
2014 ◽
Vol 73
(Suppl 2)
◽
pp. 321.1-321